首页> 外文期刊>Advanced Functional Materials >Linear Chimeric Triblock Molecules Self-Assembled Micelles with Controllably Transformable Property to Enhance Tumor Retention for Chemo-Photodynamic Therapy of Breast Cancer
【24h】

Linear Chimeric Triblock Molecules Self-Assembled Micelles with Controllably Transformable Property to Enhance Tumor Retention for Chemo-Photodynamic Therapy of Breast Cancer

机译:线性嵌合三嵌段分子自组装胶束具有可控可转换的特性,以增强乳腺癌的化学光动力疗法的肿瘤保留。

获取原文
获取原文并翻译 | 示例
           

摘要

Although nanoparticles are expected to revolutionize cancer treatment, their low efficacy remains the greatest limiting factor. Recent investigations found that nanoparticles' golden principle, the enhanced permeability and retention (EPR) effect, is limited by the complicated tumor microenvironment. Herein, novel transformable nanomaterials are designed to utilize the EPR effect more effectively. By tandem conjugation of the hydrophobic head (chlorin e6 (Ce6) or bilirubin (BR)), peptide to form hydrogen bond (Phe-Phe-Val-Leu-Lys (FFVLK)), and hydrophilic tail (polyethylene glycol (PEG)), chimeric molecules that can form micelles (Ce6/BR-FFVLK-PEG) in aqueous solution are synthesized. Notably, the spherical micelles retain shape transformability. After circulation and distribution, they respond to 650 nm laser irradiation, and morphologically change into nanofibers so as to facilitate their retention markedly inside the tumor. Upon loading a reactive oxygen species-responsive paclitaxel dimer with thioketal linker (PTX2-TK), the resultant PTX2-TK@Ce6/BR-FFVLK-PEG nanomedicine serves as a potent chemo-photodynamic therapeutic for cancer treatment. Evaluations at both cell level and animal level reveal that PTX2-TK@Ce6/BR-FFVLK-PEG exhibits superior biocompatibility and biodistribution, and suppresses 82.6% of in vitro cell growth and 61.8% of in vivo tumor growth at a common dose of intravenous injection (10 mg kg(-1) PTX and 3.3 mg kg(-1) Ce6), becoming a novel nanomedicine with extraordinary potential in cancer therapy.
机译:尽管预计纳米粒子将彻底改变癌症治疗方法,但其低效率仍然是最大的限制因素。最近的研究发现,纳米颗粒的黄金原理,即增强的渗透性和保留(EPR)效果受到复杂的肿瘤微环境的限制。本文中,设计了新颖的可变形纳米材料以更有效地利用EPR效应。通过串联偶联疏水性头部(氯霉素e6(Ce6)或胆红素(BR)),肽以形成氢键(Phe-Phe-Val-Leu-Lys(FFVLK))和亲水性尾巴(聚乙二醇(PEG))合成了可以在水溶液中形成胶束的嵌合分子(Ce6 / BR-FFVLK-PEG)。值得注意的是,球形胶束保留了形状可变形性。经过循环和分布后,它们对650 nm激光辐射产生响应,并在形态上转变为纳米纤维,从而促进它们在肿瘤内部的显着保留。加载带有硫酮连接子(PTX2-TK)的反应性氧物种响应性紫杉醇二聚体后,所得的PTX2-TK @ Ce6 / BR-FFVLK-PEG纳米药物可作为有效的化学光动力疗法用于癌症治疗。在细胞水平和动物水平的评估表明,PTX2-TK @ Ce6 / BR-FFVLK-PEG表现出优异的生物相容性和生物分布,并且在常规剂量的静脉内静脉注射时抑制了82.6%的体外细胞生长和61.8%的体内肿瘤生长。注射(10 mg kg(-1)PTX和3.3 mg kg(-1)Ce6),成为在癌症治疗中具有非凡潜力的新型纳米药物。

著录项

  • 来源
    《Advanced Functional Materials》 |2019年第23期|1808462.1-1808462.16|共16页
  • 作者单位

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

    Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada;

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

    Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug,Educ Minist, Chengdu 610064, Sichuan, Peoples R China|Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610064, Sichuan, Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    breast cancer; combinational therapy; irradiation responsiveness; retention effect; transformable nanomedicines;

    机译:乳腺癌;联合治疗;辐射反应性;保留效果;可转化的纳米药物;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号